Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT00897858
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed CNS tumors of any of the following histologies:
* Diffuse pontine gliomas\*
* Focal/infiltrative tumors, including any of the following:
* High- and low-grade gliomas
* Gangliogliomas
* Ependymomas
* Oligodendrogliomas
* Craniopharyngioma
* Dysembryoplastic neuroepithelial tumors
* Other low-grade neoplasms
* Optic pathway gliomas\*
* Seeding tumors, including any of the following:
* Germ cell tumors (germinomas and nongerminomas)
* Embryonal tumors, including any of the following:
* Medulloblastoma
* Pineoblastoma
* Supratentorial primitive neuroectodermal tumors
* Atypical teratoid/rhabdoid tumor
* Other embryonal tumors NOTE: \*Histological requirement waived
* Newly diagnosed disease
* Cerebrospinal fluid (CSF) obtained as part of CSF diversion, initial diagnosis/staging, or administration of intrathecal chemotherapy (at the initiation of postoperative therapy)
PATIENT CHARACTERISTICS:
* Less than 22 years of age
PRIOR CONCURRENT THERAPY:
* No prior radiotherapy or chemotherapy
* Prior corticosteroids allowed
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT00897858
Study Brief:
Protocol Section:
NCT00897858